Search
Search peptides and research.
Search by name or question to find peptide reviews, fact checks, guides, and sources.
Tip: press / to focus. Press Esc to clear.
What do the evidence levels mean?
These labels give a quick guide. Established means strong evidence supports one defined use. Emerging means studies in people exist, but important questions remain. Insufficient means reliable studies in people are missing or too limited.
12 results · starting points
Exact names come first.Semaglutide
This review covers Ozempic, Rybelsus, Wegovy, and the Wegovy HD strength. Their forms, approved uses, and labels differ.
Insulin
Insulin is a family of diabetes medicines. Different products can have different timing, risks, and instructions.
“Semaglutide is FDA-approved.”
FDA approves a specific product for specific uses. The current Wegovy label lists different forms, groups of people, uses, and limits.
“Compounded semaglutide is the same as an approved product.”
FDA says compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness, or quality before marketing.
OZEMPIC (semaglutide) prescribing information, revised 05/2026
U.S. Food and Drug Administration · Drug label · 2026
RYBELSUS (semaglutide) prescribing information, revised 10/2025
U.S. Food and Drug Administration · Drug label · 2025
Active ingredient
The part of a drug intended to cause its main effect. Its name alone does not tell you what the whole product is.
Adverse event
A health problem reported after someone receives a product. It may not have been caused by the product.
What are peptides?
What peptides are, what they may do, safety limits, uses, and product details.
How to read peptide research
How study design and results help you judge a source.
Metabolic peptide medicines
Compare approved medicines, peptides still being studied, and peptide fragments sold in wellness products. They are not the same category.
Growth hormone peptides
Separate a measured hormone change from claims about muscle, fat loss, recovery, or longer life.